Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.15 Million USD | 74.67% |
| 2022 | 659.78 Thousand USD | -4.47% |
| 2021 | 690.67 Thousand USD | 1111.77% |
| 2020 | 56.99 Thousand USD | 1082.27% |
| 2019 | 4821.00 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 308.68 Thousand USD | -19.5% |
| 2024 Q1 | 383.47 Thousand USD | -37.72% |
| 2023 Q4 | 615.75 Thousand USD | 177.52% |
| 2023 FY | 1.15 Million USD | 74.67% |
| 2023 Q3 | 221.87 Thousand USD | 30.57% |
| 2023 Q2 | 169.92 Thousand USD | 17.26% |
| 2023 Q1 | 144.92 Thousand USD | 116.08% |
| 2022 Q2 | 204.74 Thousand USD | -13.25% |
| 2022 Q1 | 236.02 Thousand USD | -14.32% |
| 2022 FY | 659.78 Thousand USD | -4.47% |
| 2022 Q4 | 67.06 Thousand USD | -55.86% |
| 2022 Q3 | 151.95 Thousand USD | -25.78% |
| 2021 Q1 | 117.12 Thousand USD | 400.43% |
| 2021 FY | 690.67 Thousand USD | 1111.77% |
| 2021 Q2 | 127.02 Thousand USD | 8.45% |
| 2021 Q4 | 275.48 Thousand USD | 61.07% |
| 2021 Q3 | 171.03 Thousand USD | 34.64% |
| 2020 Q2 | 8973.00 USD | 0.0% |
| 2020 FY | 56.99 Thousand USD | 1082.27% |
| 2020 Q4 | 23.4 Thousand USD | 49.59% |
| 2020 Q3 | 15.64 Thousand USD | 74.37% |
| 2020 Q1 | 8973.00 USD | 0.0% |
| 2019 FY | 4821.00 USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 98.807% |
| AngioDynamics, Inc. | 303.91 Million USD | 99.621% |
| AtriCure, Inc. | 399.24 Million USD | 99.711% |
| Avinger, Inc. | 7.65 Million USD | 84.939% |
| Azenta, Inc. | 665.07 Million USD | 99.827% |
| BioLife Solutions, Inc. | 143.27 Million USD | 99.196% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.968% |
| Daxor Corporation | 1.28 Million USD | 9.999% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | 93.695% |
| Femasys Inc. | 1.07 Million USD | -7.51% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 98.973% |
| Hologic, Inc. | 4.03 Billion USD | 99.971% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.949% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.984% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 95.959% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 99.404% |
| Innovative Eyewear, Inc. | 1.15 Million USD | 0.0% |
| Masimo Corporation | 2.04 Billion USD | 99.944% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 98.813% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 99.908% |
| Nephros, Inc. | 14.23 Million USD | 91.906% |
| NovoCure Limited | 509.33 Million USD | 99.774% |
| NEXGEL, Inc. | 4.08 Million USD | 71.815% |
| NEXGEL, Inc. | 4.08 Million USD | 71.815% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | 60.41% |
| OraSure Technologies, Inc. | 405.47 Million USD | 99.716% |
| Pro-Dex, Inc. | 53.84 Million USD | 97.86% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | 35.257% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | 93.967% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.962% |
| Repligen Corporation | 638.76 Million USD | 99.82% |
| Sanara MedTech Inc. | 64.98 Million USD | 98.227% |
| STAAR Surgical Company | 322.41 Million USD | 99.643% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 97.705% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.971% |
| Jin Medical International Ltd. | 19.82 Million USD | 94.186% |